Hilltop National Bank »

Fate Therapeutics shares owned by Hilltop National Bank

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Hilltop National Bank from 13F filings

Historical chart of Hilltop National Bank investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Hilltop National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Hilltop National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1k 285 7.34

More positions owned by Hilltop National Bank

Microsoft Corporation (MSFT)
Vanguard S&p 500 Etf Shs (VOO)
iShares ETFs/USA Msci Eafe Etf (EFA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Core S&p500 Etf (IVV)
Berkshire Hathaway Cl B New (BRK.B)
Vanguard ETF/USA Mcap Vl Idxvip (VOE)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Ishares Gold Trust Ishares New (IAU)
Pepsi (PEP)
Berkshire Hathaway Cl A (BRK.A)
iShares ETFs/USA Rus Md Cp Gr Etf (IWP)
Vanguard Etf/usa Ftse Emr Mkt Etf (VWO)

View all positions for Hilltop National Bank

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Boxer Capital
Bellevue Group
Johnson & Johnson
Citadel Advisors
Morgan Stanley
D. E. Shaw & Co
Suvretta Capital Management
Assenagon Asset Management
Holocene Advisors
Deerfield Management Company
Adage Capital Partners GP
Goldman Sachs Group

View all funds holding Fate Therapeutics